Stockscreener 앱 받기
5.00
0.60%
0.03
Leonabio Inc 주식(LONA)의 최신 뉴스
LeonaBio Opens Warrant Exercise Window for New Capital - The Globe and Mail
LeonaBio at Cantor healthcare conference: bets on ESR1 combo edge By Investing.com - Investing.com South Africa
LeonaBio at Cantor healthcare conference: bets on ESR1 combo edge By Investing.com - Investing.com India
LeonaBio at Cantor healthcare conference: bets on ESR1 combo edge By Investing.com - Investing.com Canada
LeonaBio (LONA) Stock Analysis Report | Financials & Insights - Benzinga España
LeonaBio to Participate in Cantor Global Healthcare Conference 2026 - Yahoo Finance
A drug developer's New York fireside chat is set for Sept. 11 - Stock Titan
Perceptive Advisors LLC Expands LeonaBio Inc (LONA) Stake in Str - GuruFocus
Sermonix Pharmaceuticals Discloses Investment at LeonaBio, Inc. with 36.9% Stake - TradingView
Prefunded warrants drive Sermonix-led LeonaBio (LONA) share shakeup - Stock Titan
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail
LeonaBio Reaches Key Phase 3 Enrollment Milestone - TipRanks
Perceptive's LeonaBio (NASDAQ: LONA) stake nears its ownership limit - Stock Titan
Anders Hove reports new passive stake in LeonaBio (LONA) - Stock Titan
LONA Maintained by Mizuho -- Price Target Lowered to $15.00 - GuruFocus
Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Nigeria
Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com South Africa
Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com India
Mizuho lowers LeonaBio stock price target on higher OpEx - Investing.com
Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Canada
Mizuho lowers LeonaBio stock price target on higher OpEx - Investing.com
Analysts Are Bullish on These Healthcare Stocks: Cooper Co (COO), LeonaBio (LONA) - The Globe and Mail
LeonaBio Reports Narrower Quarter Loss as Trial Progresses - sekbernews.id
LeonaBio: ELAINE-3 Enrollment Reaches 495 Of About 600 Patients As Up To $146 Million Of Warrant Proceeds Could Support Upcoming Milestones - Pulse 2.0
LeonaBio (LONA) Market Close: Closes 3.19% Higher at $7.96 at the Close; Level Check: the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotLow Volatility Picks - vinanet.vn
Analysts Offer Insights on Healthcare Companies: Elicio Therapeutics (ELTX), EyePoint Pharmaceuticals (EYPT) and LeonaBio (LONA) - The Globe and Mail
LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks
LeonaBio Inc. (LONA) Climbs 2.84% to $8.19 as Biotech Buyers Target $8.60 ResistanceWedge Breakout - vinanet.vn
LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks
LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks
LONA Maintained by Citizens -- Price Target Lowered to $17.00 - GuruFocus
LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances - Yahoo Finance
LeonaBio beats second quarter loss estimates By Investing.com - Investing.com Nigeria
LeonaBio beats second quarter loss estimates By Investing.com - Investing.com Australia
LeonaBio beats second quarter loss estimates - Investing.com
LeonaBio beats second quarter loss estimates By Investing.com - Investing.com Canada
LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks
LeonaBio beats second quarter loss estimates - Investing.com
LeonaBio Inc (LONA) Q2 Results Highlight Challenges for Valuatio - GuruFocus
Citizens lowers LeonaBio stock price target to $17 on valuation By Investing.com - Investing.com Canada
LeonaBio Inc. (LONA) Climbs 2.84% to $8.19 as Biotech Buyers Target $8.60 ResistanceEarnings Quality Factor - dars.gov.et
LeonaBio Q2 Results: EPS beats estimate, losses narrow 55% YoY - scanx.trade
LeonaBio Narrows Q2 Loss - marketscreener.com
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
LeonaBio (LONA) loss widens as cash burn rises and going concern risk emerges - Stock Titan
LeonaBio Q2 net loss widens on higher R&D spending - TradingView
LeonaBio Posts $19.0 Million Q2 Loss as ELAINE-3 Enrollment Advances - Quiver Quantitative
LeonaBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
LeonaBio, Inc. (NASDAQ: LONA) Share Price, LONA Stock News, LONA Share Price & Updates - Kalkine
7.34%
자본화:
|
볼륨(24시간):